Frontlight ResearchEarly access
Trial site
Eastern Shore Research Institute
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Heart failure4 trials
- Stroke4 trials
- Atrial fibrillation2 trials
- Familial hypercholesterolaemia2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed2 trials
- Lead sponsor
- Amgen4 trials
- Novartis Pharmaceuticals3 trials
- Regeneron Pharmaceuticals2 trials
- Cordio Medical1 trial
- Reprieve Cardiovascular, Inc1 trial
Running trials
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Coronary artery disease2 recruiting
- Heart failure2 recruiting
- Stroke2 recruiting
- Chronic kidney disease1 recruiting
- Obesity1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026